Witz I P
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.
J Cell Biochem Suppl. 2000;34:61-6.
Progression of tumor cells toward a high malignancy phenotype and metastasis is a multi-event cascade involving inter alia alterations in the expression of various genes. The focus of our laboratory is on genes whose altered expression may lead, directly or indirectly, to an increased malignancy phenotype. The identification of such genes and the evaluation of the consequences of their altered expression is essential for attempts to halt tumor progression and prevent metastasis formation. Published work originating in our laboratory showed that members of the murine Ly-6 supergene family are involved in the progression of certain mouse tumors. The expression level of several members of this family was higher on highly malignant cells than on tumor cells expressing a lower malignancy phenotype. Sorting by flow cytometry of tumor cells to subpopulations expressing either high or low levels of Ly-6E.1 yielded correspondingly cells expressing a high or a low malignancy phenotype. The high malignancy, high Ly-6E.1-expressing cells also expressed high levels of the receptor for urokinase plasminogen activator (uPAR), whereas low malignancy, low Ly-6E.1-expressing cells also expressed low levels of uPAR. Transfection studies indicated that uPAR was causally involved in conferring a high malignancy phenotype upon tumor cells expressing high levels of Ly-6E.1. E48 is a human homologue of the murine ThB protein, a member of the Ly-6 supergene family (but distinct from the Ly-6E.1 protein mentioned above) and expressed on head and neck squamous carcinoma cells. Experiments currently in progress are aimed to find out whether E48 is involved in the progression of such cancer cells. Using the differential display technology, it was shown that ligation of E48 on tumor cells by the corresponding antibodies (serving as a surrogate for an as yet unidentified E48 ligand) upregulates an enzyme (FX) involved in the biosynthesis of GDP-L-fucose. Fucose is an essential component of certain selectin ligands.
肿瘤细胞向高恶性表型和转移的进展是一个多事件级联反应,尤其涉及多种基因表达的改变。我们实验室的重点是那些表达改变可能直接或间接导致恶性表型增加的基因。鉴定此类基因并评估其表达改变的后果对于阻止肿瘤进展和预防转移形成的尝试至关重要。我们实验室发表的研究表明,小鼠Ly-6超基因家族的成员参与了某些小鼠肿瘤的进展。该家族的几个成员在高恶性细胞上的表达水平高于表达较低恶性表型的肿瘤细胞。通过流式细胞术将肿瘤细胞分选成表达高水平或低水平Ly-6E.1的亚群,相应地产生了表达高或低恶性表型的细胞。高恶性、高表达Ly-6E.1的细胞也高水平表达尿激酶型纤溶酶原激活剂(uPAR)受体,而低恶性、低表达Ly-6E.1的细胞也低水平表达uPAR。转染研究表明,uPAR因果性地参与赋予表达高水平Ly-6E.1的肿瘤细胞高恶性表型。E48是小鼠ThB蛋白的人类同源物,ThB蛋白是Ly-6超基因家族的成员(但与上述Ly-6E.1蛋白不同),在头颈部鳞状癌细胞上表达。目前正在进行的实验旨在查明E48是否参与此类癌细胞的进展。使用差异显示技术表明,用相应抗体(作为尚未鉴定的E48配体的替代物)连接肿瘤细胞上的E48会上调一种参与GDP-L-岩藻糖生物合成的酶(FX)。岩藻糖是某些选择素配体的重要组成部分。